Muhammad Luqman Nordin, Ahmad Khusairi Azemi, N. Ismail, A. H. Nordin, W. Nabgan, Nur Amalina Noralidin, R. Shaari, Nur Zul Izzati Mohd Rajdi, M. Reduan, H. N. Siti, A. H. Rasool, N. N. I. N. Ibrahim
{"title":"Canine mammary carcinoma: current therapeutic targets and future perspectives – a review","authors":"Muhammad Luqman Nordin, Ahmad Khusairi Azemi, N. Ismail, A. H. Nordin, W. Nabgan, Nur Amalina Noralidin, R. Shaari, Nur Zul Izzati Mohd Rajdi, M. Reduan, H. N. Siti, A. H. Rasool, N. N. I. N. Ibrahim","doi":"10.2478/aoas-2022-0085","DOIUrl":null,"url":null,"abstract":"Abstract Canine mammary carcinoma (CMC) is the most common neoplasm in bitches, and it shares many biological similarities with breast cancer in humans. Drug resistance, high epigenetic mutations, and relapse rates are among the challenges which eventually urge the need for a veterinary oncologist to discover new therapeutic approaches that are more effective and safer. Therefore, in this review, we also cover the current therapeutic strategies from human medicine for the future perspectives of tumor immunotherapy in veterinary medicine. These strategies have great potential to be employed as therapeutic or prophylactic options due to their ability to modulate a specific and potent immune response against CMC. As we acquire a better understanding of canine tumor immunology, we can move towards a brighter prognosis. Additionally, we report on the recent successful studies in breast cancer that may benefit canines as well.","PeriodicalId":8235,"journal":{"name":"Annals of Animal Science","volume":"23 1","pages":"703 - 716"},"PeriodicalIF":1.8000,"publicationDate":"2023-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Animal Science","FirstCategoryId":"97","ListUrlMain":"https://doi.org/10.2478/aoas-2022-0085","RegionNum":4,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"AGRICULTURE, DAIRY & ANIMAL SCIENCE","Score":null,"Total":0}
引用次数: 0
Abstract
Abstract Canine mammary carcinoma (CMC) is the most common neoplasm in bitches, and it shares many biological similarities with breast cancer in humans. Drug resistance, high epigenetic mutations, and relapse rates are among the challenges which eventually urge the need for a veterinary oncologist to discover new therapeutic approaches that are more effective and safer. Therefore, in this review, we also cover the current therapeutic strategies from human medicine for the future perspectives of tumor immunotherapy in veterinary medicine. These strategies have great potential to be employed as therapeutic or prophylactic options due to their ability to modulate a specific and potent immune response against CMC. As we acquire a better understanding of canine tumor immunology, we can move towards a brighter prognosis. Additionally, we report on the recent successful studies in breast cancer that may benefit canines as well.
期刊介绍:
Annals of Animal Science accepts original papers and reviews from the different topics of animal science: genetic and farm animal breeding, the biology, physiology and reproduction of animals, animal nutrition and feedstuffs, environment, hygiene and animal production technology, quality of animal origin products, economics and the organization of animal production.